dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | García-Layana, A |
dc.contributor.author | Recalde, Sergio |
dc.contributor.author | Hernandez, Maria |
dc.contributor.author | Abraldes, Maximino |
dc.contributor.author | Nascimento, João |
dc.contributor.author | Hernández-Galilea, Emiliano |
dc.contributor.author | Zapata Victori, Miguel Angel |
dc.date.accessioned | 2022-01-13T13:04:38Z |
dc.date.available | 2022-01-13T13:04:38Z |
dc.date.issued | 2021-04 |
dc.identifier.citation | García-Layana A, Recalde S, Hernandez M, Abraldes MJ, Nascimento J, Hernández-Galilea E, et al. A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration. Nutrients. 2021 Apr;13(4):1253. |
dc.identifier.issn | 2072-6643 |
dc.identifier.uri | https://hdl.handle.net/11351/6781 |
dc.description | Carotenoides; Marcadors inflamatoris; Àcids grassos poliinsaturats |
dc.description.sponsorship | The research was funded by Laboratorios Théa (Barcelona, Spain) and by research grants from the “Instituto de Salud Carlos III/European Regional Development Fund (ERDF)” and RD16/0008/0011, OFTARED: Enfermedades oculares: “Prevención, detección precoz, tratamiento y rehabilitación de las patologías oculares”. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Nutrients;13(4) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Degeneració macular - Tractament |
dc.subject | Medicaments - Eficàcia |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Macular Degeneration |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.title | A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/nu13041253 |
dc.subject.decs | degeneración macular |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.3390/nu13041253 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [García-Layana A, Recalde S, Hernandez M] Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain. Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain. Red Temática de Investigación Cooperativa Sanitaria en Enfer-Medades Oculares (Oftared), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Abraldes MJ] Red Temática de Investigación Cooperativa Sanitaria en Enfer-Medades Oculares (Oftared), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Nascimento J] Retinal Department, Ophthalmology, Retina Lisbon Institut, 1050-085 Lisbon, Portugal. [Hernández-Galilea E] Department of Ophthalmology, University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain. [Zapata MA] Servei d’Oftalmologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33920232 |
dc.identifier.wos | 000643404600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0008%2F0011 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |